1. Home
  2. SLGL vs SFWL Comparison

SLGL vs SFWL Comparison

Compare SLGL & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • SFWL
  • Stock Information
  • Founded
  • SLGL 1997
  • SFWL 2001
  • Country
  • SLGL Israel
  • SFWL China
  • Employees
  • SLGL N/A
  • SFWL N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • SFWL Trucking Freight/Courier Services
  • Sector
  • SLGL Health Care
  • SFWL Industrials
  • Exchange
  • SLGL Nasdaq
  • SFWL Nasdaq
  • Market Cap
  • SLGL 69.1M
  • SFWL 82.3M
  • IPO Year
  • SLGL 2018
  • SFWL 2023
  • Fundamental
  • Price
  • SLGL $29.01
  • SFWL $1.12
  • Analyst Decision
  • SLGL
  • SFWL
  • Analyst Count
  • SLGL 0
  • SFWL 0
  • Target Price
  • SLGL N/A
  • SFWL N/A
  • AVG Volume (30 Days)
  • SLGL 25.3K
  • SFWL 24.9K
  • Earning Date
  • SLGL 08-15-2025
  • SFWL 08-27-2025
  • Dividend Yield
  • SLGL N/A
  • SFWL N/A
  • EPS Growth
  • SLGL N/A
  • SFWL 31.68
  • EPS
  • SLGL N/A
  • SFWL 0.14
  • Revenue
  • SLGL $23,931,000.00
  • SFWL $540,461,000.00
  • Revenue This Year
  • SLGL N/A
  • SFWL N/A
  • Revenue Next Year
  • SLGL $31.17
  • SFWL N/A
  • P/E Ratio
  • SLGL N/A
  • SFWL $8.07
  • Revenue Growth
  • SLGL 264.86
  • SFWL 21.10
  • 52 Week Low
  • SLGL $4.01
  • SFWL $0.86
  • 52 Week High
  • SLGL $30.98
  • SFWL $1.60
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 65.45
  • SFWL 51.90
  • Support Level
  • SLGL $23.15
  • SFWL $1.12
  • Resistance Level
  • SLGL $30.98
  • SFWL $1.28
  • Average True Range (ATR)
  • SLGL 2.27
  • SFWL 0.07
  • MACD
  • SLGL 0.00
  • SFWL -0.00
  • Stochastic Oscillator
  • SLGL 74.90
  • SFWL 33.33

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About SFWL Shengfeng Development Limited

Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.

Share on Social Networks: